Best Practice & Research Clinical Rheumatology
Volume 23, Issue 5 , Pages 599-608, October 2009

Using biology of disease to understand and guide therapy of JIA

  • Berent J. Prakken, MD, PhD (Professor)

      Affiliations

    • Department of Pediatric Immunology/Rheumatology, University Medical Centre Utrecht, Wilhelmina Children's Hospital, Lundlaan 6/Postbus 85090, 3584 EA/3508 AB Utrecht, The Netherlands
    • Eureka Institute for Translational Medicine, EU, USA
    • ,
  • Salvatore Albani, MD, PhD (The Charles and Suzanne Stephens Chair of Rheumatology Research, Professor of Medicine and Pediatrics, and Director Arizona Arthritis Center)

      Affiliations

    • Arizona Arthritis Center, University of Arizona, 1501 N. Campbell Avenue, PO Box 245093, Tucson, AZ 85724-5093, USA
    • Eureka Institute for Translational Medicine, EU, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 520 626 7902; Fax +1 520 626 5018.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1521-6942(09)00074-6

doi:10.1016/j.berh.2009.07.003

Best Practice & Research Clinical Rheumatology
Volume 23, Issue 5 , Pages 599-608, October 2009

Article Tools